Do All Patients With Congenital Hip Dysplasia Corrected Operatively Need Physiotherapy
NCT ID: NCT05238935
Last Updated: 2022-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2022-02-23
2023-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
all individuals diagnosed with DDH and operated by Dr. Saleh Alsaifi (an orthopedic surgeon at alrazi orthopedic hospital) will be invited to participate in this study. The study will look at the children development in fictional ability postoperatively. not being referred to physiotherapy is a common practice, so the patients in the intervention group will benefit from having regular physiotherapy treatment with no risk at all. the study run from Alrazi orthopedic hospital in kuwait. the research is a collaboration between an orthopedic surgeon (Dr. Saleh Alsaifi) and physiotherapy team and it is expected to recruit all of the eligible patients through 12 months period (approximately 50 patients) then, the data will be sorted for analysis and reporting. the study is not funded with no personal interest.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Guided Growth Technique Use In Treatment Of Hip Sublaxation In CP Childern
NCT06983353
Physical Therapy Applications on the Hip and Defined Functional Parameters in Children With Developmental Hip Dysplasia
NCT06007833
Developmental Hip Dysplasia and Physical Therapy
NCT04006574
Effect of Weight on Hip Excursion During Gait
NCT05579535
Late-presenting Hip Dislocation in Non-ambulatory Children With Cerebral Palsy: A Comparison of Three Procedures
NCT05593887
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study will consist of children aged 1.5-5 who's guardian voluntarily agreed to participate in the study. It is planned to involve up to 50 children. Individuals who meet the inclusion criteria and had their guardian agreed to volunteer will be included in the study by signing the Informed Voluntary Consent Form. The participants will be examined by the responsible examiner in physiotherapy clinic (blinded to the allocated group). Patients in the control group will be given a home program by the orthopedic surgeon (common practice). Patients in the intervention group will be treated with conventional physiotherapy 3 times a week for 6 weeks (4 times evaluation and 18 times treatment).
As an outcome measure, the examiner will evaluate patient's hip function (using modified outcome evaluation standard for congenital dislocation of the hip by Zhou and Ji) and pediatric balance scale. patient will have a baseline data preoperatively. Then, patient will have the first postoperative evaluation10 weeks post-operatively (time of the removal of spica cast). After the first post-operative evaluation, individuals will be treated 3 times a week for 3 weeks and then the first evaluations will be done again then the same process will be repeated. Thus, Patient will be evaluated four times by the same examiner (before the operation, after 10 weeks \[removal of spica cast\], after 3 weeks of treatment \[13 weeks postoperatively\] and after 6 weeks of treatment \[16 weeks postoperatively\]). The data obtained before and after treatment and the data between the two groups will be compared.
Primary outcome measure modified outcome evaluation standard for congenital dislocation of the hip by Zhou will be used to evaluate child's functional level and Ji and pediatric balance scale will be used to evaluate child's balance. both outcome measures will be through physical examination of hip joint range of motion and some physical examination. the tests will be obtained 4 times (preoperative, postoperative base line (after the removal of the spica cast), 3 weeks post operative, 6 weeks postoperative)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
this group will be treated as per the common practice postoperatively and will have the home program prescribed by the orthopedic surgeon
No interventions assigned to this group
intervention (treatment) group
Patients in the intervention group will be treated with conventional physiotherapy 3 times a week for 6 weeks (18 times treatment).
prescribed physiotherapy course
provide full assessment and treatment program as postoperative rehabilitation management
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
prescribed physiotherapy course
provide full assessment and treatment program as postoperative rehabilitation management
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient is able to walk preoperatively
* aged between 1.5-5
Exclusion Criteria
* patient with neurological involvement
* patient with other congenital deformity
* patient with cognitive problems
18 Months
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, Kuwait
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Hadeel Alsaleh
physiotherapy and rehabilitation specialist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. Hadeel Alsaleh
Kuwait City, , Kuwait
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
maryam alsaffar, master
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
maryam Alsaffar, master
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1920
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.